- Spring 2015Novartis Pharms. Corp. v. Mylan Inc.
- Spring 2015AstraZeneca LP v. Breath Ltd.
- Spring 2015Senju Pharm. Co., Ltd. v. Metrics, Inc.
- Spring 2015Teva Pharms USA, Inc. v. Sandoz, Inc.
- Spring 2015Spectrum Pharms., Inc. v. Sandoz Inc.
- Spring 2015New ANDA Cases
- Spring 2015Senju Pharm. Co., Ltd. v. Lupin Ltd.
- April 14, 2015Litigation Management for the In-House Generalist: Insurance, Indemnification and Litigation Holds
- April 13, 2015How Gelboim V BofA Affects Pending MDL Matters
- Spring 2015ANDA Approvals
- April, 2015You First: Manufacturing, IP, and the Coming 3D Printing Disruption
- March 31, 2015Companies Should Rethink Their European Patent Strategy
- March 31, 2015Litigation Management for the InHouse Generalist Receiving Complaints
- March 26, 2015Large-Packaged Goods and Robinson-Patman: Manufacturers Beware
- March 24, 2015SEPs Don't Need A Different Reasonable Royalty Analysis
- March 20, 2015Ex-U.S. Attorney to Fight for Indian Rights
- March 19, 2015Former US Attorney reflects on Indian cases
- March 18, 20153D Printing and Intellectual Property Law: Predictions for 2015
- March 17, 2015Litigation Management for the In-House Generalist: The Commencement Phase
- March 16, 2015Drafting a Better Nondisclosure Agreement
- March 16, 2015Eschew Obfuscation – Writing is for Communication
- March 13, 2015New Strategies for Venue in Hatch-Waxman Litigation
- March 11, 2015A New 'Footprint' Paradigm For Reasonable Royalty Damages
- March 2, 2015Legislature Bolsters Sales Rep Termination Act
- March 2015Patent Litigation, Chapter 12: Trial
- February 26, 2015Keeping Secrets in the Cloud: Are Storms Ahead For Trade Secret Protection?
- February 23, 2015Consumer Goods and Retail Roundtable
- February 20, 2015In the Interest of Justice
- A Modest Proposal to Disturb the Sound of Appellate Silence: Why the Eighth Circuit Should Articulate a Rule 23(f) Standard for Appeals of Class Certification Decisions
- February 12, 2015Taking the Pulse of Digital Health: Key Legal Issues Surrounding Wearable Technology
- Winter 2014Mylan Pharms., Inc. v. FDA
- Winter 2014Spectrum Pharms., Inc. v. Sandoz Inc.,
- Winter 2014Sandoz Inc. v. Amgen Inc.,
- Winter 2014Glenmark Generics Ltd. v. Ferring B.V.,
- Winter 2014The Medicines Co. v. Mylan Inc.
- Winter 2014Par Pharm., Inc. v. TWI Pharms., Inc.,
- Winter 2014Warner Chilcott Co, LLC v. Teva Pharms. USA, Inc
- Winter 2014Pfizer Inc. v. Mylan Pharms. Inc.
- Winter 2014Allergan, Inc. v. Actavis, Inc.
- Winter 2014Cubist Pharms., Inc. v. Hospira, Inc.
- Winter 2014Bristol-Myers Squibb Co. v. Teva Pharms. USA, Inc
- Winter 2014Takeda Pharms. USA, Inc. v. West-Ward Pharm. Corp.,
- February 2, 2015Five Guidelines for Renegotiating Outsourcing Contracts
- January 29, 2015A Guide to the Internet of Things
- January 29, 2015Why New Media Should Care About 'Innocence of Muslims'
- January 25, 2015Software the Supreme Court and 3D Printing
- January 23, 2015More Coverage Issues May Go To Appraisal Panels In Minn
- January 15, 2015You Cant Judge an ECF Notice by its Cover
- January 15, 2015A new cybersecurity reality for new media companies
- 2015Preserving the Attorney-Client Privilege and Work-Production Protections Afforded to Communications with Experts: Be Careful of What You Say and to Whom You Say It
